NO20072998L - Stabilisering av glukokortikoidestere med syrer - Google Patents
Stabilisering av glukokortikoidestere med syrerInfo
- Publication number
- NO20072998L NO20072998L NO20072998A NO20072998A NO20072998L NO 20072998 L NO20072998 L NO 20072998L NO 20072998 A NO20072998 A NO 20072998A NO 20072998 A NO20072998 A NO 20072998A NO 20072998 L NO20072998 L NO 20072998L
- Authority
- NO
- Norway
- Prior art keywords
- stabilization
- acids
- glucocorticoid
- esters
- glucocorticoid esters
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004059220 | 2004-12-09 | ||
DE200510055386 DE102005055386A1 (de) | 2005-11-17 | 2005-11-17 | Stabilisierung von Glucocorticoidestern mit Säuren |
DE102005055385A DE102005055385A1 (de) | 2004-12-09 | 2005-11-17 | Arzneimittel zur hygienischen Applikation im Ohr |
PCT/EP2005/012977 WO2006061155A2 (de) | 2004-12-09 | 2005-12-03 | Stabilisierung von glucocorticoidestern mit säuren |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20072998L true NO20072998L (no) | 2007-06-12 |
Family
ID=35758903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20072998A NO20072998L (no) | 2004-12-09 | 2007-06-12 | Stabilisering av glukokortikoidestere med syrer |
Country Status (14)
Country | Link |
---|---|
US (2) | US20090239835A1 (ko) |
EP (1) | EP1827498A2 (ko) |
JP (1) | JP5002462B2 (ko) |
KR (1) | KR101217680B1 (ko) |
AU (1) | AU2005313601B2 (ko) |
BR (1) | BRPI0518853A2 (ko) |
CA (1) | CA2591296A1 (ko) |
CR (1) | CR9164A (ko) |
HK (1) | HK1117044A1 (ko) |
IL (1) | IL183743A0 (ko) |
MX (1) | MX2007006908A (ko) |
NO (1) | NO20072998L (ko) |
NZ (1) | NZ555641A (ko) |
WO (1) | WO2006061155A2 (ko) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007055341A1 (de) | 2007-11-19 | 2009-05-20 | Bayer Animal Health Gmbh | Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren |
GR20090100230A (el) | 2009-04-14 | 2010-11-18 | Casso Pharmaceuticals Ε.Π.Ε, | Απο του στοματος εναιωρημα οξικης δεξαμεθανοζης-συνθεση καλυψης γευσης της δεξαμεθανοζης |
US9757388B2 (en) | 2011-05-13 | 2017-09-12 | Acerus Pharmaceuticals Srl | Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels |
AR086400A1 (es) | 2011-05-13 | 2013-12-11 | Trimel Pharmaceuticals Corp | Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo |
US20130045958A1 (en) | 2011-05-13 | 2013-02-21 | Trimel Pharmaceuticals Corporation | Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
KR20230041081A (ko) * | 2011-05-15 | 2023-03-23 | 에이세러스 바이오파마 인크. | 비내용 테스토스테론 바이오-접착제 겔 제형 및 남성의 성선기능저하증을 치료하기 위한 그의 용도 |
US11744838B2 (en) | 2013-03-15 | 2023-09-05 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
US10111956B2 (en) | 2013-06-03 | 2018-10-30 | Tolmar, Inc. | Corticosteroid compositions |
JP2016520656A (ja) * | 2013-06-03 | 2016-07-14 | トルマー,インコーポレイティド | コルチコステロイド組成物 |
JP7033789B2 (ja) * | 2016-06-29 | 2022-03-11 | オトノミー,インク. | トリグリセリド耳用製剤とその使用 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6032714B2 (ja) | 1978-07-04 | 1985-07-30 | 新日本製鐵株式会社 | 表面処理鋼板 |
JPS5524131A (en) * | 1978-08-09 | 1980-02-21 | Nippon Redarii Kk | Synthetic adrenal cortical hormone preparation ointment and its base |
JPS6028923B2 (ja) | 1979-05-28 | 1985-07-08 | 三井化学株式会社 | エレクトレツト化捲縮繊維の製法 |
US4670444B1 (en) * | 1980-09-03 | 1999-02-09 | Bayer Ag | and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds |
JPS6032714A (ja) * | 1983-08-01 | 1985-02-19 | Teijin Ltd | 鼻腔粘膜に適用するための安定化された粉末状薬学的組成物 |
DE3333719A1 (de) * | 1983-09-17 | 1985-04-04 | Bayer Ag | Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren |
GB8420771D0 (en) * | 1984-08-15 | 1984-09-19 | Efamol Ltd | Treatment of skin disorders |
JPS61167614A (ja) * | 1985-01-22 | 1986-07-29 | Mitsubishi Yuka Yakuhin Kk | ステロイド含有軟膏剤 |
DE3537761A1 (de) * | 1985-10-24 | 1987-04-30 | Bayer Ag | Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure |
DE3713672A1 (de) * | 1987-04-24 | 1988-11-17 | Bayer Ag | Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren |
US5444096A (en) * | 1989-06-02 | 1995-08-22 | Helene Curtis, Inc. | Stable anhydrous topically-active composition and suspending agent therefor |
DE19500784A1 (de) * | 1995-01-13 | 1996-07-18 | Bayer Ag | Enrofloxacin-Injektions- oder Infusionslösungen |
CA2176298C (en) * | 1995-06-27 | 2009-01-27 | Dennis D. Copeland | A single high dose fluoroquinolone treatment |
US5972920A (en) * | 1998-02-12 | 1999-10-26 | Dermalogix Partners, Inc. | Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders |
US6585997B2 (en) * | 2001-08-16 | 2003-07-01 | Access Pharmaceuticals, Inc. | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
-
2005
- 2005-12-03 JP JP2007544786A patent/JP5002462B2/ja not_active Expired - Fee Related
- 2005-12-03 BR BRPI0518853-9A patent/BRPI0518853A2/pt not_active IP Right Cessation
- 2005-12-03 CA CA002591296A patent/CA2591296A1/en not_active Abandoned
- 2005-12-03 EP EP05812509A patent/EP1827498A2/de not_active Ceased
- 2005-12-03 WO PCT/EP2005/012977 patent/WO2006061155A2/de active Application Filing
- 2005-12-03 NZ NZ555641A patent/NZ555641A/en not_active IP Right Cessation
- 2005-12-03 AU AU2005313601A patent/AU2005313601B2/en not_active Ceased
- 2005-12-03 MX MX2007006908A patent/MX2007006908A/es active IP Right Grant
- 2005-12-03 KR KR1020077014595A patent/KR101217680B1/ko not_active IP Right Cessation
- 2005-12-13 US US11/721,209 patent/US20090239835A1/en not_active Abandoned
-
2007
- 2007-06-01 CR CR9164A patent/CR9164A/es unknown
- 2007-06-07 IL IL183743A patent/IL183743A0/en unknown
- 2007-06-12 NO NO20072998A patent/NO20072998L/no not_active Application Discontinuation
-
2008
- 2008-07-07 HK HK08107441.2A patent/HK1117044A1/xx not_active IP Right Cessation
-
2010
- 2010-11-29 US US12/954,989 patent/US20110301135A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
HK1117044A1 (en) | 2009-01-09 |
WO2006061155A2 (de) | 2006-06-15 |
BRPI0518853A2 (pt) | 2008-12-09 |
JP5002462B2 (ja) | 2012-08-15 |
JP2008522997A (ja) | 2008-07-03 |
IL183743A0 (en) | 2007-09-20 |
EP1827498A2 (de) | 2007-09-05 |
NZ555641A (en) | 2010-10-29 |
KR20070086690A (ko) | 2007-08-27 |
CR9164A (es) | 2008-03-03 |
CA2591296A1 (en) | 2006-06-15 |
US20110301135A1 (en) | 2011-12-08 |
WO2006061155A3 (de) | 2006-08-31 |
US20090239835A1 (en) | 2009-09-24 |
KR101217680B1 (ko) | 2013-01-02 |
MX2007006908A (es) | 2007-08-03 |
AU2005313601B2 (en) | 2012-05-24 |
AU2005313601A1 (en) | 2006-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20072998L (no) | Stabilisering av glukokortikoidestere med syrer | |
MY166613A (en) | Glycerol levulinate ketals and their use | |
TN2011000346A1 (en) | Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors | |
WO2007075901A3 (en) | Quinolin- 4 - one derivatives as modulators of abc transporters | |
WO2010057203A3 (en) | Hdl particles for delivery of nucleic acids | |
EA201290389A8 (ru) | Применение 1,3-дифенилпроп-2-ен-1-оновых производных для лечения заболеваний печени | |
EP3892709A3 (en) | Variants and compositions comprising variants with high stability in presence of a chelating agent | |
WO2011008495A3 (en) | Arginase formulations and methods | |
EA201500650A1 (ru) | Фенилацетат l-орнитина и способы его получения | |
WO2010146172A3 (en) | New synthetic route for the preparation of alpha-amino boronic esters | |
ATE529404T1 (de) | Phenoxyessigsäuren als ppar-delta-aktivatoren | |
ZA200810317B (en) | High-strength,low temperature stable herbicidal formulations of fluroxypyr esters | |
MX348402B (es) | Conversión de 5-(clorometil)-2-furaldehído en ácido 5-metil-2-furoico y sus derivados. | |
DK1608346T3 (da) | Lægemiddeltilförselssammensætninger af alfa-hydroxysyreester og fremgangsmåder til anvendelse heraf | |
TW200718695A (en) | Novel piperidine carboxylic acid amide derivatives | |
HK1112592A1 (en) | Composition for reducing the exudation of serum proteins | |
BRPI0814115B8 (pt) | composição farmacêutica compreendendo o composto 11-deóxi-prostaglandina e método para estabilizar o composto | |
EA200870543A1 (ru) | Нежелательные примеси к донепезилу | |
CY1112501T1 (el) | Φαρμακευτικες συνθεσεις περιεχουσες λεφλουνομιδη | |
ATE482172T1 (de) | Feste salzzubereitung, deren herstellung und verwendung | |
WO2005087718A3 (de) | Carbodiimide mit thiocarbamidsäureestergruppen | |
UA88663C2 (en) | Stabilisation of glucocorticoid esters with acids | |
GEP20125563B (en) | 2-amino-2-phenylalkanol derivatives, preparation method thereof and pharmaceutical compositions containing same | |
CY1107277T1 (el) | Βενζισοξαζολες | |
TW200602032A (en) | Processes for the preparation of 2-cyano-3-naphthalene-1-yl-acrylic acid alkyl or benzyl esters |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |